3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Uncontrolled Hypertension: new trials by email Literature Review of Uncontrolled Hypertension trials Research Report on Uncontrolled Hypertension
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension SAL0120, Placebo - Uncontrolled Hypertension, Resistant Hypertension | Phase 3 | Completed | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 256 | 2024-10-29 | 2026-08-27 |
| A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension Baxdrostat, Placebo - Uncontrolled Hypertension, Resistant Hypertension | Phase 3 | Completed | AstraZeneca | 326 | 2024-04-08 | 2026-04-21 |
| A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension Baxdrostat, Placebo - Uncontrolled Hypertension, Resistant Hypertension | Phase 3 | Completed | AstraZeneca | 796 | 2023-11-22 | 2026-07-30 |
Hypertension (2)
Cardiovascular Diseases (2) · Vascular Diseases (2)
AstraZeneca (2) · Shenzhen Salubris Pharmaceuticals Co., Ltd. (1)
Argentina (2) · Australia (2) · China (2) · India (2) · Japan (2) · South Korea (2) · Turkey (Türkiye) (2) · Vietnam (2) · Austria (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Czechia (1) · Denmark (1) · France (1)
PMID 40850955, PMID 39138914, PMID 40888730
2023 (1)